What is the current annual EBIT of ABBV?

As of today, ABBV annual EBIT is $21.21B

What is 1-year change in ABBV annual EBIT?

ABBV annual EBIT is up +27.60% year-over-year

What is 3-year change in ABBV annual EBIT?

ABBV annual EBIT is down -6.14% over the past 3 years

How far is ABBV annual EBIT from its all-time high?

ABBV annual EBIT is currently -6.14% below its historical high of $22.60B set on December 31, 2022

How does ABBV annual EBIT rank versus sector peers?

ABBV annual EBIT is higher than 99.74% of companies in Healthcare sector

When is ABBV next annual earnings release?

The next annual earnings release for ABBV is on February 3, 2027

What is the current quarterly EBIT of ABBV?

As of today, ABBV quarterly EBIT is $6.48B

What is ABBV quarterly EBIT most recent change?

ABBV quarterly EBIT was down -3.48% on September 30, 2026

What is 1-year change in ABBV quarterly EBIT?

ABBV quarterly EBIT is up +41.58% year-over-year

How far is ABBV quarterly EBIT from its all-time high?

ABBV quarterly EBIT is currently -3.48% below its historical high of $6.72B set on June 30, 2026

How does ABBV quarterly EBIT rank versus sector peers?

ABBV quarterly EBIT is higher than 99.81% of companies in Healthcare sector

When is ABBV next earnings release?

The next earnings release for ABBV is on February 3, 2027

What is the current TTM EBIT of ABBV?

As of today, ABBV TTM EBIT is $23.91B

What is ABBV TTM EBIT most recent change?

ABBV TTM EBIT was up +8.65% on September 30, 2026

What is 1-year change in ABBV TTM EBIT?

ABBV TTM EBIT is up +25.49% year-over-year

How far is ABBV TTM EBIT from its all-time high?

ABBV TTM EBIT is currently at its all-time high

How does ABBV TTM EBIT rank versus sector peers?

ABBV TTM EBIT is higher than 99.72% of companies in Healthcare sector

When is ABBV next earnings release?

The next earnings release for ABBV is on February 3, 2027

AbbVie Inc. (ABBV) EBIT History & Chart Since 2009

Annual EBIT

$21.21B$4.59B+27.60%

December 31, 2025

Summary

Current Value: As of today, ABBV annual EBIT is $21.21B, up +27.60% on December 31, 2025
Historical Performance: ABBV annual EBIT is down -6.14% over the past 3 years, up +35.73% over the past 5 years
All-Time High Comparison: ABBV annual EBIT is currently -6.14% below its historical high of $22.60B set on December 31, 2022
3-Year Low Comparison: ABBV annual EBIT is +27.60% above its 3-year low of $16.63B reached on December 31, 2024
Sector Comparison: ABBV annual EBIT is higher than 99.74% of companies in Healthcare sector

EBIT Chart

beforeafter

Performance

ABBV Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBIT	Dec 31, 25	$21.21B	+27.6%	-6.1%	+35.7%	+311.4%
Quarterly EBIT	Sep 30, 26	$6.48B	+41.6%	+42.7%	+19.9%	+9632.3%
TTM EBIT	Sep 30, 26	$23.91B	+25.5%	+13.0%	+26.5%	+849.2%
Price	Nov 13, 26	$295.03	+27.0%	+112.8%	+152.2%	–
PE Ratio	Nov 13, 26	50.78	-71.0%	+33.8%	+82.3%	–
Annual Revenue	Dec 31, 25	$61.16B	+8.6%	+5.3%	+33.5%	+291.1%
Annual EPS	Dec 31, 25	$2.36	-1.2%	-64.4%	-13.3%	-10.7%
Annual EBITDA	Dec 31, 25	$29.05B	+16.2%	-6.5%	+31.4%	+358.2%
Annual Net Income	Dec 31, 25	$4.19B	-1.3%	-64.4%	-8.1%	+0.4%

EBIT Highs

ABBV Annual EBIT Highs Comparison
Period	High	Date	Current
3Y	$22.60B	N/A	-6.1%
5Y	$22.60B	Dec 31, 22	-6.1%
All	$22.60B	Dec 31, 22	-6.1%

EBIT Lows

ABBV Annual EBIT Lows Comparison
Period	Low	Date	Current
3Y	$16.63B	Dec 31, 24	+27.6%
5Y	$15.63B	N/A	+35.7%
All	$5.14B	Dec 31, 09	+312.4%

EBIT History

Year	Value	Change
2025	$21.21B	+27.6%
2024	$16.63B	-8.1%
2023	$18.08B	-20.0%
2022	$22.60B	+14.4%
2021	$19.75B	+26.4%
2020	$15.63B	+12.3%
2019	$13.92B	+14.6%
2018	$12.14B	+14.9%
2017	$10.56B	+7.9%

Year	Value	Change
2016	$9.80B	+16.0%
2015	$8.44B	+39.6%
2014	$6.05B	-4.6%
2013	$6.34B	-4.7%
2012	$6.65B	+10.7%
2011	$6.01B	+16.5%
2010	$5.16B	+0.2%
2009	$5.14B	-

FAQ

What is the current annual EBIT of ABBV?: As of today, ABBV annual EBIT is $21.21B
What is 1-year change in ABBV annual EBIT?: ABBV annual EBIT is up +27.60% year-over-year
What is 3-year change in ABBV annual EBIT?: ABBV annual EBIT is down -6.14% over the past 3 years
How far is ABBV annual EBIT from its all-time high?: ABBV annual EBIT is currently -6.14% below its historical high of $22.60B set on December 31, 2022
How does ABBV annual EBIT rank versus sector peers?: ABBV annual EBIT is higher than 99.74% of companies in Healthcare sector
When is ABBV next annual earnings release?: The next annual earnings release for ABBV is on February 3, 2027

EBIT Formula

EBIT = Revenue − Cost Of Goods Sold − Operating Expenses

Quarterly EBIT

$6.48B$234.00M-3.48%

September 30, 2026

Summary

Current Value: As of today, ABBV quarterly EBIT is $6.48B, down -3.48% on September 30, 2026
Historical Performance: ABBV quarterly EBIT is up +41.58% year-over-year, up +42.73% over the past 3 years
All-Time High Comparison: ABBV quarterly EBIT is currently -3.48% below its historical high of $6.72B set on June 30, 2026
3-Year Low Comparison: ABBV quarterly EBIT is +116.90% above its 3-year low of $2.99B reached on March 31, 2024
Sector Comparison: ABBV quarterly EBIT is higher than 99.81% of companies in Healthcare sector

Performance

ABBV Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBIT	Sep 30, 26	$6.48B	-3.5%	+41.6%	+42.7%	+19.9%
Annual EBIT	Dec 31, 25	$21.21B	–	+27.6%	-6.1%	+35.7%
TTM EBIT	Sep 30, 26	$23.91B	+8.7%	+25.5%	+13.0%	+26.5%
Price	Nov 13, 26	$295.03	+17.6%	+27.0%	+112.8%	+152.2%
PE Ratio	Nov 13, 26	50.78	-28.4%	-71.0%	+33.8%	+82.3%
Quarterly Revenue	Sep 30, 26	$17.40B	+2.4%	+10.3%	+25.0%	+21.4%
Quarterly EPS	Sep 30, 26	$2.37	+16.7%	+2289.7%	+137.8%	+33.5%
Quarterly EBITDA	Sep 30, 26	$8.35B	-3.0%	+25.1%	+23.9%	+10.9%
Quarterly Net Income	Sep 30, 26	$4.21B	+16.7%	+2263.5%	+137.7%	+33.2%

Quarterly EBIT Highs

ABBV Quarterly EBIT Highs Comparison
Period	High	Date	Current
1Y	$6.72B	Jun 30, 26	-3.5%
3Y	$6.72B	Jun 30, 26	-3.5%
5Y	$6.72B	Jun 30, 26	-3.5%
All	$6.72B	Jun 30, 26	-3.5%

Quarterly EBIT Lows

ABBV Quarterly EBIT Lows Comparison
Period	Low	Date	Current
1Y	$4.58B	N/A	+41.6%
3Y	$2.99B	Mar 31, 24	+116.9%
5Y	$2.99B	Mar 31, 24	+116.9%
All	$66.61M	Sep 30, 11	+9632.3%

Quarterly EBIT History

Month	Value	Change
Sep 2026	$6.48B	-3.5%
Jun 2026	$6.72B	+33.7%
Mar 2026	$5.03B	-11.7%
Dec 2025	$5.69B	+24.2%
Sep 2025	$4.58B	-21.1%
Jun 2025	$5.80B	+45.1%
Mar 2025	$4.00B	-14.6%
Dec 2024	$4.68B	+18.1%
Sep 2024	$3.96B	-20.7%
Jun 2024	$4.99B	+67.1%
Mar 2024	$2.99B	-40.9%
Dec 2023	$5.06B	+11.3%
Sep 2023	$4.54B	-4.4%
Jun 2023	$4.75B	-17.7%
Mar 2023	$5.77B	-5.2%
Dec 2022	$6.09B	+4.4%
Sep 2022	$5.83B	+3.8%
Jun 2022	$5.61B	+11.8%
Mar 2022	$5.02B	-5.5%
Dec 2021	$5.31B	-1.7%
Sep 2021	$5.41B	+16.9%
Jun 2021	$4.63B	+6.1%
Mar 2021	$4.36B	-3.3%
Dec 2020	$4.51B	+27.6%
Sep 2020	$3.54B	+18.5%
Jun 2020	$2.98B	-17.6%
Mar 2020	$3.62B	+4.2%
Dec 2019	$3.47B	-4.9%
Sep 2019	$3.65B	+4.5%
Jun 2019	$3.50B	+6.2%
Mar 2019	$3.29B	+9.7%
Dec 2018	$3.00B	-8.8%

Month	Value	Change
Sep 2018	$3.29B	+17.1%
Jun 2018	$2.81B	-11.0%
Mar 2018	$3.16B	+27.1%
Dec 2017	$2.48B	-6.8%
Sep 2017	$2.66B	-3.1%
Jun 2017	$2.75B	+13.6%
Mar 2017	$2.42B	-0.1%
Dec 2016	$2.42B	-3.1%
Sep 2016	$2.50B	-1.2%
Jun 2016	$2.53B	+8.4%
Mar 2016	$2.33B	+6.6%
Dec 2015	$2.19B	+13.0%
Sep 2015	$1.94B	-13.9%
Jun 2015	$2.25B	+18.7%
Mar 2015	$1.90B	+31.4%
Dec 2014	$1.44B	-0.1%
Sep 2014	$1.44B	-13.5%
Jun 2014	$1.67B	+15.6%
Mar 2014	$1.45B	-14.5%
Dec 2013	$1.69B	+2.1%
Sep 2013	$1.66B	+0.5%
Jun 2013	$1.65B	+22.2%
Mar 2013	$1.35B	-31.6%
Dec 2012	$1.97B	+8.3%
Sep 2012	$1.82B	+13.4%
Jun 2012	$1.61B	+29.1%
Mar 2012	$1.24B	-32.3%
Dec 2011	$1.83B	+2,654.5%
Sep 2011	$66.61M	-95.7%
Jun 2011	$1.54B	+69.1%
Mar 2011	$911.44M	-

FAQ

What is the current quarterly EBIT of ABBV?: As of today, ABBV quarterly EBIT is $6.48B
What is ABBV quarterly EBIT most recent change?: ABBV quarterly EBIT was down -3.48% on September 30, 2026
What is 1-year change in ABBV quarterly EBIT?: ABBV quarterly EBIT is up +41.58% year-over-year
How far is ABBV quarterly EBIT from its all-time high?: ABBV quarterly EBIT is currently -3.48% below its historical high of $6.72B set on June 30, 2026
How does ABBV quarterly EBIT rank versus sector peers?: ABBV quarterly EBIT is higher than 99.81% of companies in Healthcare sector
When is ABBV next earnings release?: The next earnings release for ABBV is on February 3, 2027

EBIT Formula

EBIT = Revenue − Cost Of Goods Sold − Operating Expenses

TTM EBIT

$23.91B$1.90B+8.65%

September 30, 2026

Summary

Current Value: As of today, ABBV TTM EBIT is $23.91B, up +8.65% on September 30, 2026
Historical Performance: ABBV TTM EBIT is up +25.49% year-over-year, up +13.04% over the past 3 years
All-Time High Comparison: ABBV TTM EBIT is currently at its all-time high
3-Year Low Comparison: ABBV TTM EBIT is +43.84% above its 3-year low of $16.63B reached on December 31, 2024
Sector Comparison: ABBV TTM EBIT is higher than 99.72% of companies in Healthcare sector

Performance

ABBV Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBIT	Sep 30, 26	$23.91B	+8.7%	+25.5%	+13.0%	+26.5%
Annual EBIT	Dec 31, 25	$21.21B	–	+27.6%	-6.1%	+35.7%
Quarterly EBIT	Sep 30, 26	$6.48B	-3.5%	+41.6%	+42.7%	+19.9%
Price	Nov 13, 26	$295.03	+17.6%	+27.0%	+112.8%	+152.2%
PE Ratio	Nov 13, 26	50.78	-28.4%	-71.0%	+33.8%	+82.3%
TTM Revenue	Sep 30, 26	$66.01B	+2.5%	+10.7%	+19.7%	+19.7%
TTM EPS	Sep 30, 26	$5.81	+64.3%	+338.4%	+59.0%	+38.4%
TTM EBITDA	Sep 30, 26	$31.60B	+5.6%	+15.4%	+5.6%	+14.8%
TTM Net Income	Sep 30, 26	$10.30B	+64.2%	+337.5%	+58.8%	+38.0%

TTM EBIT Highs

ABBV TTM EBIT Highs Comparison
Period	High	Date	Current
1Y	$23.91B	Sep 30, 26	at high
3Y	$23.91B	Sep 30, 26	at high
5Y	$23.91B	Sep 30, 26	at high
All	$23.91B	Sep 30, 26	at high

TTM EBIT Lows

ABBV TTM EBIT Lows Comparison
Period	Low	Date	Current
1Y	$19.06B	N/A	+25.5%
3Y	$16.63B	Dec 31, 24	+43.8%
5Y	$16.63B	Dec 31, 24	+43.8%
All	$911.44M	Mar 31, 11	+2523.7%

TTM EBIT History

Month	Value	Change
Sep 2026	$23.91B	+8.7%
Jun 2026	$22.01B	+4.3%
Mar 2026	$21.09B	+5.1%
Dec 2025	$20.06B	+5.3%
Sep 2025	$19.06B	+3.3%
Jun 2025	$18.44B	+4.6%
Mar 2025	$17.63B	+6.1%
Dec 2024	$16.63B	-2.2%
Sep 2024	$17.00B	-3.3%
Jun 2024	$17.58B	+1.4%
Mar 2024	$17.34B	-13.8%
Dec 2023	$20.12B	-4.9%
Sep 2023	$21.15B	-5.7%
Jun 2023	$22.44B	-3.7%
Mar 2023	$23.30B	+3.3%
Dec 2022	$22.55B	+3.6%
Sep 2022	$21.78B	+2.0%
Jun 2022	$21.35B	+4.8%
Mar 2022	$20.37B	+3.3%
Dec 2021	$19.71B	+4.2%
Sep 2021	$18.91B	+11.0%
Jun 2021	$17.04B	+10.7%
Mar 2021	$15.39B	+5.1%
Dec 2020	$14.65B	+7.6%
Sep 2020	$13.61B	-0.9%
Jun 2020	$13.73B	-3.6%
Mar 2020	$14.24B	+2.4%
Dec 2019	$13.92B	+3.5%
Sep 2019	$13.44B	+2.8%
Jun 2019	$13.08B	+5.6%
Mar 2019	$12.39B	+1.1%
Dec 2018	$12.26B	+4.4%

Month	Value	Change
Sep 2018	$11.74B	+5.6%
Jun 2018	$11.11B	+0.6%
Mar 2018	$11.05B	+7.2%
Dec 2017	$10.31B	+0.6%
Sep 2017	$10.25B	+1.6%
Jun 2017	$10.08B	+2.2%
Mar 2017	$9.87B	+0.9%
Dec 2016	$9.78B	+2.4%
Sep 2016	$9.55B	+6.2%
Jun 2016	$8.99B	+3.2%
Mar 2016	$8.71B	+5.3%
Dec 2015	$8.27B	+9.9%
Sep 2015	$7.53B	+7.0%
Jun 2015	$7.03B	+9.0%
Mar 2015	$6.45B	+7.5%
Dec 2014	$6.00B	-4.0%
Sep 2014	$6.25B	-3.3%
Jun 2014	$6.46B	+0.4%
Mar 2014	$6.44B	+1.5%
Dec 2013	$6.34B	-4.3%
Sep 2013	$6.62B	-2.4%
Jun 2013	$6.79B	+0.6%
Mar 2013	$6.75B	+1.6%
Dec 2012	$6.64B	+2.1%
Sep 2012	$6.50B	+36.9%
Jun 2012	$4.75B	+1.4%
Mar 2012	$4.69B	+7.6%
Dec 2011	$4.35B	+72.8%
Sep 2011	$2.52B	+2.7%
Jun 2011	$2.45B	+169.1%
Mar 2011	$911.44M	-

FAQ

What is the current TTM EBIT of ABBV?: As of today, ABBV TTM EBIT is $23.91B
What is ABBV TTM EBIT most recent change?: ABBV TTM EBIT was up +8.65% on September 30, 2026
What is 1-year change in ABBV TTM EBIT?: ABBV TTM EBIT is up +25.49% year-over-year
How far is ABBV TTM EBIT from its all-time high?: ABBV TTM EBIT is currently at its all-time high
How does ABBV TTM EBIT rank versus sector peers?: ABBV TTM EBIT is higher than 99.72% of companies in Healthcare sector
When is ABBV next earnings release?: The next earnings release for ABBV is on February 3, 2027

EBIT Formula

EBIT = Revenue − Cost Of Goods Sold − Operating Expenses

Data Sources & References

ABBV Official Website www.abbvie.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm
ABBV Profile on Yahoo Finance finance.yahoo.com/quote/ABBV
ABBV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/abbv